| 23/12/24 | 07:00:05 | 23 Dec 2024 | | Results of RetailBook Offer | RNS |
| 06/12/24 | 11:31:00 | 6 Dec 2024 | | RetailBook Offer | RNS |
| 06/12/24 | 11:30:00 | 6 Dec 2024 | | Subscription by AOP Health to raise US$10 million | RNS |
| 21/11/24 | 07:00:06 | 21 Nov 2024 | | Business Update | RNS |
| 29/10/24 | 07:00:07 | 29 Oct 2024 | | Q3 Trading Update | RNS |
| 25/09/24 | 07:00:02 | 25 Sept 2024 | | Results from Phase 3 paediatric study | RNS |
| 04/09/24 | 07:00:08 | 4 Sept 2024 | | Interim results | RNS |
| 27/08/24 | 07:00:07 | 27 Aug 2024 | | ACCRUFeR® Approved by Health Canada | RNS |
| 14/08/24 | 07:00:11 | 14 Aug 2024 | | Notice of interim results | RNS |
| 24/07/24 | 07:01:01 | 24 Jul 2024 | | Unaudited Q2 2024 Trading Update | RNS |
| 24/07/24 | 07:00:10 | 24 Jul 2024 | | Directorate Change | RNS |
| 03/07/24 | 07:00:09 | 3 Jul 2024 | | $5.7m Milestone Monetization Agreement with AOP | RNS |
| 20/06/24 | 16:25:41 | 20 Jun 2024 | | Results of 2024 Annual General Meeting | RNS |
| 28/05/24 | 07:00:17 | 28 May 2024 | | New Drug Application for Accrufer® in South Korea | RNS |
| 10/05/24 | 15:30:18 | 10 May 2024 | | Audited results for the year ended 31 Dec 2023 | RNS |
| 30/04/24 | 07:00:11 | 30 Apr 2024 | | Business Update for Q1 2024 | RNS |
| 16/04/24 | 07:00:13 | 16 Apr 2024 | | Notice of Results | RNS |
| 21/02/24 | 07:00:06 | 21 Feb 2024 | | Unaudited Full Year Trading Update | RNS |
| 09/01/24 | 07:00:04 | 9 Jan 2024 | | Appointment of new Chief Financial Officer | RNS |
| 07/12/23 | 07:00:07 | 7 Dec 2023 | | Q3 2023 U.S. Commercial Highlights | RNS |
| 27/11/23 | 17:24:38 | 27 Nov 2023 | | PDMR Transaction Notification | RNS |
| 20/10/23 | 11:45:00 | 20 Oct 2023 | | Abstract to be presented at Healthcare Conference | RNS |
| 12/10/23 | 07:00:09 | 12 Oct 2023 | | Chief Financial Officer Transition | RNS |
| 03/10/23 | 15:00:01 | 3 Oct 2023 | | Result of REX Retail Offer | RNS |
| 03/10/23 | 07:00:09 | 3 Oct 2023 | | Block listing Interim Return | RNS |
| 03/10/23 | 07:00:06 | 3 Oct 2023 | | Completion of SWK Financing | RNS |
| 28/09/23 | 12:50:02 | 28 Sept 2023 | | Successful completion of US$6.1m Equity Fundraise | RNS |
| 28/09/23 | 07:02:02 | 28 Sept 2023 | | REX Retail Offer | RNS |
| 28/09/23 | 07:01:02 | 28 Sept 2023 | | $20m secured debt facility &proposed equity raise | RNS |
| 28/09/23 | 07:00:10 | 28 Sept 2023 | | Interim results update and business update | RNS |
| 06/09/23 | 07:00:06 | 6 Sept 2023 | | Notice of Results and Change in reporting currency | RNS |
| 24/07/23 | 14:27:13 | 24 Jul 2023 | | Holding(s) in Company | RNS |
| 20/07/23 | 07:00:06 | 20 Jul 2023 | | Business Update and U.S. Q2 2023 Highlights | RNS |
| 28/06/23 | 17:30:01 | 28 Jun 2023 | | Results of 2023 Annual General Meeting | RNS |
| 16/06/23 | 12:00:01 | 16 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 15/06/23 | 16:35:01 | 15 Jun 2023 | | Lapse of Offer | RNS |
| 15/06/23 | 12:00:02 | 15 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 15/06/23 | 07:00:04 | 15 Jun 2023 | | Acceptance Level Update | RNS |
| 14/06/23 | 12:00:01 | 14 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 14/06/23 | 07:00:09 | 14 Jun 2023 | | Acceptance Level Update | RNS |
| 13/06/23 | 12:00:01 | 13 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 13/06/23 | 07:00:05 | 13 Jun 2023 | | Acceptance Level Update | RNS |
| 12/06/23 | 12:00:02 | 12 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 12/06/23 | 07:00:04 | 12 Jun 2023 | | Acceptance Level Update | RNS |
| 09/06/23 | 12:00:02 | 9 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 09/06/23 | 07:00:04 | 9 Jun 2023 | | Acceptance Level Update | RNS |
| 08/06/23 | 12:31:21 | 8 Jun 2023 | | Form 8.3 - Shield Therapeutics PLC (amendment) | RNS |
| 08/06/23 | 12:00:03 | 8 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
| 08/06/23 | 07:00:07 | 8 Jun 2023 | | Acceptance Level Update | RNS |
| 07/06/23 | 12:00:02 | 7 Jun 2023 | | Form 8.5 (EPT/RI) - Shield Therapeutics Plc | RNS |
